V. Kerlan
-
- Diabetes Management and Research 12
- Pituitary Gland Disorders and Treatments 12
- Diabetes Treatment and Management 6
- Reproductive Medicine top 5%
- Genetics top 5%
- Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities 6
- Cancer Research top 10%
- Pharmacology top 5%
-
- Adrenal and Paraganglionic Tumors 8
-
- Sexual Differentiation and Disorders 8
-
- Neuroendocrine Tumor Research Advances 7
-
- Reproductive Biology and Fertility 5
- Co-authors
- Nathalie RoudautDominique MottierEmmanuel OgerKarine LacutMarie‐Thérèse BlouchJean‐François AbgrallPierre‐Yves ScarabinAnne‐Paule Gimenez‐Roqueplo
- Journals
- Diabetes & Metabolism (9 papers)Clinical Endocrinology (5 papers)European Journal of Endocrinology (3 papers)
- Partner nations
- FranceUnited StatesSwitzerland
In The Last Decade
V. Kerlan
82 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 117
- Endocrinology, Diabetes and Metabolism 786
- Reproductive Medicine 205
- Genetics 450
- Cancer Research 186
- Pharmacology 88
Countries citing papers authored by V. Kerlan
This map shows the geographic impact of V. Kerlan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Kerlan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Kerlan more than expected).
Fields of papers citing papers by V. Kerlan
This network shows the impact of papers produced by V. Kerlan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Kerlan. The network helps show where V. Kerlan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside V. Kerlan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 17 | |
| 3 | 2022 | 10 | |
| 4 | 2022 | 3 | |
| 5 | 2021 | 53 | |
| 6 | 2019 | 8 | |
| 7 | 2017 | 3 | |
| 8 | 2017 | 0 | |
| 9 | 2016 | 146 | |
| 10 | 2015 | 4 | |
| 11 | 2012 | 4 | |
| 12 | 2012 | 3 | |
| 13 | 2012 | 5 | |
| 14 | 2012 | 1 | |
| 15 | 2012 | 17 | |
| 16 | 2010 | 5 | |
| 17 | 2003 | 207 | |
| 18 | 2002 | 171 | |
| 19 | NEOPLASIE ENDOCRINIENNE MULTIPLE TYPE 1, EFFECT DE L'OCTREOTIDE SUR L'HYPERPARATHYROIDIE | 1993 | 1 |
| 20 | 1989 | 1 |
About V. Kerlan
V. Kerlan is a scholar working on Endocrinology, Diabetes and Metabolism, Reproductive Medicine, Obstetrics and Gynecology, Genetics and Periodontics, having authored 90 papers that have together received 1.6k indexed citations. Recurring topics across this work include Diabetes Management and Research (12 papers), Pituitary Gland Disorders and Treatments (12 papers), Adrenal and Paraganglionic Tumors (8 papers), Sexual Differentiation and Disorders (8 papers), Neuroendocrine Tumor Research Advances (7 papers), Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (6 papers), Diabetes Treatment and Management (6 papers) and Reproductive Biology and Fertility (5 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (786 citations), Reproductive Medicine (205 citations), Genetics (450 citations), Cancer Research (186 citations) and Pharmacology (88 citations). V. Kerlan has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include Nathalie Roudaut, Dominique Mottier, Emmanuel Oger, Karine Lacut, Marie‐Thérèse Blouch, Jean‐François Abgrall, Pierre‐Yves Scarabin, Anne‐Paule Gimenez‐Roqueplo, Judith Favier and B Charbonnel. Their work appears in journals such as Diabetes & Metabolism, Clinical Endocrinology, European Journal of Endocrinology, The Journal of Clinical Endocrinology & Metabolism and Annales d Endocrinologie.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.